| 2026-08-11 | Press release | Revvity to Present at Upcoming Investor Conferences |
| 2026-08-11 | 10-Q | Form 10-Q for the quarter ended Jul 5 |
| 2026-08-04 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-04 | Press release | Revvity Announces Financial Results for the Second Quarter of 2026 |
| 2026-08-04 | Deck | Earnings Presentation · Q2 2026 |
| 2026-08-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-31 | Press release | Revvity Board Declares Quarterly Dividend |
| 2026-07-29 | Supplement | Non-GAAP Reconciliations · Q3 2026 |
| 2026-07-08 | Press release | Download , Revvity to Hold Earnings Call on Tuesday, August 4, 2026 |
| 2026-07-01 | Press release | Download , Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration |
| 2026-06-22 | Press release | Download , Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D, (open |
| 2026-05-13 | Press release | Revvity to Present at Upcoming Investor Conferences |
| 2026-05-13 | Transcript | Earnings call transcript |
| 2026-05-12 | 10-Q | Form 10-Q for the quarter ended Apr 5 |
| 2026-05-05 | Press release | Download , Revvity Announces Financial Results for the First Quarter of 2026 |
| 2026-05-05 | Deck | Earnings presentation · Q1 2026 · May 2026 |
| 2026-05-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-05 | Transcript | Q1 FY26 earnings call transcript |
| 2026-05-04 | Supplement | Non-GAAP Reconciliations · Q1 2026 |
| 2026-05-01 | 8-K | Form 8-K, Item 5.03 |
| 2026-04-30 | Press release | Download , Revvity Board Declares Quarterly Dividend |
| 2026-04-16 | Press release | Download , Revvity to Present at Upcoming Investor Conferences |
| 2026-04-10 | Press release | Download , Revvity to Hold Earnings Call on Tuesday, May 5, 2026 |
| 2026-04-09 | Press release | Download , Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows, (opens |
| 2026-03-16 | Proxy | Definitive proxy statement |
| 2026-03-02 | Press release | Revvity to Present at Upcoming Investor Conferences |
| 2026-02-24 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-17 | Press release | Download , Revvity to Present at Upcoming Investor Conferences |
| 2026-02-05 | Press release | Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 |
| 2026-02-02 | Press release | Download , Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025, (opens in |
| 2026-02-02 | Deck | Earnings presentation · Q4 2025 · Feb 2026 |
| 2026-02-02 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-02 | Transcript | Q4 FY25 earnings call transcript |
| 2026-01-30 | Supplement | Non-GAAP Reconciliations of Q4 2025 Report |
| 2026-01-26 | Press release | Download , Revvity Board Declares Quarterly Dividend |
| 2026-01-13 | Deck | JP Morgan Conference 2026 Presentation Open Event Link |
| 2026-01-13 | Press release | Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance |
| 2026-01-13 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-12 | Press release | Download , Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance, January |
| 2026-01-09 | Press release | Download , Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models, (opens in new |